The psychostimulant methylphenidate was used to treat 30 depressed cancer patients in whom rapid response and minimization of the usual side effects of tricyclic antidepressants were desirable. Ten showed marked improvement and 13 moderate improvement, achieved within days and with few side effects. Eleven of these patients were treated for a year without evidence of tolerance or abuse.